Regulation of host cell gene expression by the hepatitis C virus protein NS5A
丙型肝炎病毒蛋白 NS5A 对宿主细胞基因表达的调节
基本信息
- 批准号:8251563
- 负责人:
- 金额:$ 6.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-01-01 至 2013-12-31
- 项目状态:已结题
- 来源:
- 关键词:3&apos Untranslated RegionsAdverse effectsAffectAntibodiesBindingCell DeathCell LineCell ProliferationCellsCessation of lifeChronicCirrhosisDataDissectionDown-RegulationElementsExhibitsGene ExpressionGene TargetingGenesGrowthHepatitis CHepatitis C virusHuman Cell LineImmunoprecipitationIndiumInfectionLaboratoriesLiver CirrhosisLiver FibrosisLiver diseasesMalignant NeoplasmsMediatingMessenger RNANonstructural ProteinNorthern BlottingOligonucleotide MicroarraysPharmaceutical PreparationsPlayPrimary carcinoma of the liver cellsProtein BindingProteinsProto-OncogenesRNARegulationReporterResearchReverse Transcriptase Polymerase Chain ReactionRoleSmall Interfering RNASpottingsTranscriptViralViral ProteinsVirusVirus InhibitorsVirus Replicationhepatoma cellinhibitor/antagonistinnovationknock-downmRNA DecaymRNA Transcript Degradationmortalitynoveloverexpressionparticlepreventresponsestandard care
项目摘要
DESCRIPTION (provided by applicant): Hepatitis C virus (HCV) is a major cause of liver disease and mortality, affecting approximately 170 million people worldwide. Chronic infection with HCV leads to liver fibrosis, cirrhosis and hepatocellular carcinoma. HCV must use the host gene expression machinery to facilitate viral replication. The mechanisms involved in the replication are incompletely understood. It has been found that the HCV nonstructural protein NS5A is essential to the replication machinery of the virus and critical in the assembly of infectious viral particles, however its specific role remains unclear. Recent preliminary data from the Bohjanen's laboratory indicates that the HCV NS5A protein binds to host GRE-containing transcripts and mediates their stabilization in hepatoma cell lines. This data suggest that HCV could manipulate host cellular mRNA decay through NS5A- mediated stabilization of GRE-containing transcripts. Stabilization of these transcripts would prevent cell death and promote growth of virus -infected cells allowing the virus to establish chronic infection in the host. In this study, we aim to identify host cellular transcripts that bind to the hepatitis C virus non-structural protein and to determine if the NS5A inhibitor BMS 790052 blocks HCV replication through interference with the binding of NS5A to GRE-containing host cellular transcripts. Further understanding of the critical genes involved in RNA regulation of HCV in human cell lines, will help characterize the virus replication cycle. In addition, it will expose genes of critical importance, thus unveiling potential targets for treatment. Moreover, dissection of the downstream effects of NS5A inhibitors will expose additional weak spots in the HCV replication machinery, expanding our understanding of the virus and facilitating innovation of new therapies.
描述(由申请人提供):丙型肝炎病毒(HCV)是肝病和死亡率的主要原因,影响了全球约1.7亿人。 HCV慢性感染会导致肝纤维化,肝硬化和肝细胞癌。 HCV必须使用宿主基因表达机制来促进病毒复制。复制所涉及的机制尚未完全理解。已经发现,HCV非结构蛋白NS5A对于病毒的复制机制至关重要,在传染性病毒颗粒组装中至关重要,但是其特定作用尚不清楚。 Bohjanen实验室的最新初步数据表明,HCV NS5A蛋白与含有GRE的转录本结合,并介导其在肝癌细胞系中的稳定性。该数据表明,HCV可以通过NS5A介导的含GRE的转录本的稳定来操纵宿主细胞mRNA衰变。这些转录本的稳定将防止细胞死亡并促进病毒感染的细胞的生长,从而使病毒在宿主中建立慢性感染。在这项研究中,我们旨在确定与乙型肝炎病毒非结构蛋白结合的宿主细胞转录本,并确定NS5A抑制剂BMS 790052是否通过干扰NS5A与含GRE宿主细胞的宿主细胞转录物的结合来阻止HCV复制。进一步了解人类细胞系中HCV的RNA调节的关键基因将有助于表征病毒复制周期。此外,它将暴露重要性至关重要的基因,从而揭示了治疗的潜在靶标。此外,对NS5A抑制剂的下游效应的解剖会暴露于HCV复制机制中的其他弱点,从而扩展了我们对病毒的理解并促进新疗法的创新。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jose Daniel Debes其他文献
Jose Daniel Debes的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jose Daniel Debes', 18)}}的其他基金
Immune profiling to detect viral hepatitis-related liver cancer in HIV-infected patients
免疫分析检测 HIV 感染者中病毒性肝炎相关肝癌
- 批准号:
10703227 - 财政年份:2022
- 资助金额:
$ 6.1万 - 项目类别:
Impact of Hepatitis C and HIV coinfection on biological aging and hepatocellular carcinoma risk
丙型肝炎和艾滋病毒合并感染对生物衰老和肝细胞癌风险的影响
- 批准号:
10872804 - 财政年份:2022
- 资助金额:
$ 6.1万 - 项目类别:
Immune profiling to detect viral hepatitis-related liver cancer in HIV-infected patients
免疫分析检测 HIV 感染者中病毒性肝炎相关肝癌
- 批准号:
10536532 - 财政年份:2022
- 资助金额:
$ 6.1万 - 项目类别:
Regulation of host cell gene expression by the hepatitis C virus protein NS5A
丙型肝炎病毒蛋白 NS5A 对宿主细胞基因表达的调节
- 批准号:
8400739 - 财政年份:2012
- 资助金额:
$ 6.1万 - 项目类别:
相似海外基金
The role of extracellular vesicle-associated MicroRNAs in HIV-associated atherosclerosis
细胞外囊泡相关 MicroRNA 在 HIV 相关动脉粥样硬化中的作用
- 批准号:
10619831 - 财政年份:2023
- 资助金额:
$ 6.1万 - 项目类别:
IL-17A mRNA-targeted oligonucleotide therapeutics in Idiopathic Pulmonary Fibrosis (IPF)
IL-17A mRNA 靶向寡核苷酸治疗特发性肺纤维化 (IPF)
- 批准号:
10761365 - 财政年份:2023
- 资助金额:
$ 6.1万 - 项目类别:
miRNA site-blocking ASOs as MeCP2 targeted therapeutics
miRNA 位点阻断 ASO 作为 MeCP2 靶向治疗
- 批准号:
10648126 - 财政年份:2023
- 资助金额:
$ 6.1万 - 项目类别:
Modulation of RNA Binding Proteins in Xenobiotic-induced Hepatotoxicity
RNA 结合蛋白在异生素诱导的肝毒性中的调节
- 批准号:
10587498 - 财政年份:2023
- 资助金额:
$ 6.1万 - 项目类别:
Alternative polyadenylation regulation in Trypanosoma brucei
布氏锥虫的替代多腺苷酸化调控
- 批准号:
10584834 - 财政年份:2022
- 资助金额:
$ 6.1万 - 项目类别: